Study type: In vivo/preclinical · Status: Citation identity verified
Electrophysiological evidence that the vasoactive intestinal chemical sequence receptor antagonist VIP6-28 reduces nociception in an animal model of osteoarthritis.
Osteoarthritis and cartilage · 2006
Study scale: Not reported
Citation only: Open source record
Product or molecular entity relationships
- VIP: Catalog source association. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Not reported in the reviewed source.
Methods
Not reported in the reviewed source.
Scale or participants
Not reported in the reviewed source.
Key findings
Not reported in the reviewed source.
Limitations and uncertainty
Not reported in the reviewed source.
Citation identity verified. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.